Pleural fluid concentrations of glucose, adenosine deaminase (ADA), white blood cells (WBCs), lactate dehydrogenase (LDH), and protein were collected from the medical records of the participants. Pleural glucose was determined by the hexokinase method. LDH was determined by the lactate‐to‐pyruvate method. ADA was determined by the peroxidase method.
Au5800 biochemical analyzer
The AU5800 biochemical analyzer is a clinical chemistry system designed for high-volume laboratories. It is capable of performing a wide range of clinical chemistry, immunoassay, and special chemistry tests. The AU5800 utilizes various analytical technologies to provide accurate and reliable results.
Lab products found in correlation
16 protocols using au5800 biochemical analyzer
Pleural Fluid Biomarker Analysis Protocol
Pleural fluid concentrations of glucose, adenosine deaminase (ADA), white blood cells (WBCs), lactate dehydrogenase (LDH), and protein were collected from the medical records of the participants. Pleural glucose was determined by the hexokinase method. LDH was determined by the lactate‐to‐pyruvate method. ADA was determined by the peroxidase method.
Metabolic Profile Assessment Protocol
Blood samples were taken for biochemical analysis after a 10 h fast. Within one hour of collection, plasma was separated from the blood and stored at 30 °C until analysis of the fasting plasma glucose (FPG) and lipid profiles. The FPG level was measured using a glucose oxidase method (YSI 203 glucose analyzer, Yellow Springs Instruments, Yellow Springs, OH, USA). Total cholesterol and triglyceride (TG) levels were measured using a dry, multilayer, analytical slide method with the Fuji Dri-Chem 3000 analyzer (Fuji Photo Film, Tokyo, Japan). Serum high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) concentrations were analyzed using an enzymatic cholesterol assay following dextran sulfate precipitation. The urine microalbumin was determined by turbidimetry using the Beckman Coulter AU 5800 biochemical analyzer.
Cardiovascular Risk Factors Assessment
Anthropometric and Biochemical Measurements
Biochemical Markers in Clinical Study
The serum TAFI levels were measured by immune turbidimetry using kits provided by Liaoning Maidi Biological Technology and analyzed by the AU480 automatic biochemical analyzer (Beckman Coulter, Brea, CA, United States).
Fungal Biomarker Detection Protocols
Kinetic-turbidimetric LAL kit and microbial dynamic monitoring system (ELX 808) were used to test serum BDG. The concentration of serum BDG ≥10 μg/ml was identified as a positive specimen as per instructions. The minimum detection limit is 10 μg/ml for this methodology.
Serum PCT was measured by electrochemiluminescence technique using the Cobas 6000 system (Roche Diagnostic, Germany). Serum CRP was measured by AU5800 Biochemical analyzer (Beckman Coulter, USA). Sputum and BALF cultures were measured using Sabouraud fungal medium and identified by spectrum analyzer (Microflex LT/SH).
Comparative Analysis of APE and NSTEMI
Comprehensive Metabolic Profiling
Comprehensive Biomarker Analysis in APL
Dialysis Patient Blood and Urine Analysis
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!